Back to Search Start Over

LABORATORY STUDIES TO DETERMINE THE HIGH DOSE STATUS OF VIPCOT™ COTTON.

LABORATORY STUDIES TO DETERMINE THE HIGH DOSE STATUS OF VIPCOT™ COTTON.

Authors :
O'Reilly, David R.
Walters, Fred
Palekar, Narendra
Boyer, Ashley
Kurtz, Ryan W.
Source :
Proceedings of the Beltwide Cotton Conferences; 2007, p1087-1094, 8p, 2 Charts, 4 Graphs
Publication Year :
2007

Abstract

Syngenta is currently developing VipCot™, a transgenic insect-resistant cotton that expresses both Vip3A and Cry1Ab insecticidal proteins. These proteins were combined through the traditional breeding of two independent events, each expressing one of the two proteins. The mode-of-action of Vip3A is different from that of Cry1Ab, and there is no cross-resistance between these proteins. Therefore, from an Insect Resistance Management (IRM) perspective, a stack of Vip3A and Cry1Ab will represent an excellent and sustainable product for cotton lepidopteran pest control. We are currently evaluating the high dose status of VipCot™ to support the IRM strategy proposed for the product. In this paper, data from two laboratory-based methods assessing the high dose status of VipCot™ are presented. [ABSTRACT FROM AUTHOR]

Details

Language :
English
Database :
Supplemental Index
Journal :
Proceedings of the Beltwide Cotton Conferences
Publication Type :
Conference
Accession number :
36953338